Cardiovascular safety of the tyrosine kinase inhibitor nintedanib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiovascular safety of the tyrosine kinase inhibitor nintedanib

Published:2021-03-08 Issue:10 Volume:87 Page:3690-3698
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Brit Jnl Clinical Pharma

Author:

Ameri Pietro¹²^ORCID,Tini Giacomo¹²,Spallarossa Paolo¹,Mercurio Valentina³,Tocchetti Carlo Gabriele³⁴,Porto Italo¹²

Affiliation:

1. Cardiovascular Disease Unit IRCCS Ospedale Policlinico San Martino – IRCCS Italian Cardiology Network Genoa Italy

2. Department of Internal Medicine University of Genova Genoa Italy

3. Department of Translational Medical Sciences Federico II University Naples Italy

4. Interdepartmental Center of Clinical and Translational Sciences (CIRCET) Federico II University Naples Italy

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14793

Reference92 articles.

1. Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New Millennium

2. Therapeutic targets in idiopathic pulmonary fibrosis

3. BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy

4. Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

5. Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the pathways of drug repurposing and Panax ginseng treatment mechanisms in chronic heart failure: a disease module analysis perspective;Scientific Reports;2024-05-27

2. Ischaemic heart disease in patients with cancer;European Heart Journal;2024-02-07

3. Efficacy and safety of nintedanib in patients with non-small cell lung cancer, and novel insights in radiation-induced lung toxicity;Frontiers in Oncology;2023-08-10

4. Identification of cardiotoxicity related to non-small cell lung cancer (NSCLC) treatments: A systematic review;Frontiers in Pharmacology;2023-06-13

5. Cell-Based Phenotypic Screen for Antifibrotic Compounds Targets Eicosanoid Metabolism;Circulation Research;2023-01-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3